Florean C, Lernoux M, Lorant A, Losson H, Bormans G, Schnekenburger M, Diederich M. HDAC6 inhibitors sensitize resistant t(11;14) multiple myeloma cells to a combination of bortezomib and BH3 mimetics. haematol [Internet]. 2020Sep.10 [cited 2024Oct.14];. Available from: https://haematologica.org/article/view/haematol.2024.286279